Do the Clinical Data Support the Use of DES with Biodegradable Polymers over DES with Durable Polymers? - Robert Byrne, MB BCh, PhD

↳ This is a section part of Moment: CRT 2016 Technology & Innovation - Biodegradable Polymer DES Programs

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$5.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Do the Clinical Data Support the Use of DES with Biodegradable Polymers over DES with Durable Polymers? presented by Robert Byrne, MB BCh, PhD at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$5.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Interventional Cardiologists
Interventional Fellows

Session Name: Biodegradable Polymer DES Programs

Track: Technology & Innovation

Learning Objectives

Update in advances with bioresorbable & DCB technologies in interventional procedures

Other Components in this Moment

Overview

Do the Clinical Data Support the Use of DES with Biodegradable Polymers over DES with Durable Polymers? - Robert Byrne, MB BCh, PhD

Everolimus-Eluting Bioabsorbable-Polymer DES Outcomes: SYNERGY Update - Dean Kereiakes, MD, FACC, FSCAI

EXCELLA Novolimus Elution from PLLA Polymer-Coated Stents - Stefan Verheye, MD, PhD

Orsiro: PLLA/Sirolimus Biodegradable: The BIOFLOW Studies Indepth - Thomas Pilgrim, MD

Combo: A Combination of Sirolimus-Eluting Biodegradable Polymer and Anti-CD34 Antibody Coated Stent - Mitchell Krucoff, MD, FSCAI

Emerging Programs of DES with Biodegradable Polymers - Ricardo Costa, PhD